Imaging for molecular and pathological subtyping of hepatocellular carcinoma—a critical appraisal and future directions - Top-Institutions - MDSpire

Imaging for molecular and pathological subtyping of hepatocellular carcinoma—a critical appraisal and future directions

  • By

  • Xinyuan Jia

  • Hanyu Jiang

  • Zheng Ye

  • Hong Wei

  • Jie Chen

  • Yali Qu

  • Claude B. Sirlin

  • Bin Song

  • Yanshu Wang

  • October 30, 2025

  • 0 min

Share

Top Institutions in Radiology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hepatology
    • Radiology
    • Oncology
    • Molecular Pathology

  • #2

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Hepatology
    • Radiology
    • Molecular Oncology

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hepatology
    • Radiology
    • Pathology

  • #4

    National Cancer Institute (NCI) - NIH
    National Cancer Institute (NCI) - NIH

    Bethesda, MD

    Key Differentiators

    • Cancer Research
    • Radiology
    • Molecular Biology

  • #5

    Stanford University Medical Center
    Stanford University Medical Center

    Stanford, CA

    Key Differentiators

    • Hepatology
    • Radiology
    • Genomics

Original Source(s)

Imaging for molecular and pathological subtyping of hepatocellular carcinoma—a critical appraisal and future directions

  • by Xinyuan Jia, Hanyu Jiang, Zheng Ye, Hong Wei, Jie Chen, Yali Qu, Claude B. Sirlin, Bin Song, Yanshu Wang

  • October 30, 2025

Related Content

Quality over quantity: biopsy-anchored CT radiogenomics models outperform all-lesion training in a multi-tumour cohort despite a smaller sample size

AI Drafts Cut Radiograph Reporting Time

Prospective cohort study found faster documentation, with no statistically significant difference in peer-reviewed report quality

Early prediction of immune checkpoint inhibitor-related pneumonitis in advanced non-small cell lung cancer based on primary tumor Delta-radiomics features